Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reticulon-4, also known as Nogo-A, is a membrane-associated protein encoded by the RTN4 gene, primarily expressed in the central nervous system. It is the most well-characterized inhibitor of neurite outgrowth, limiting neuronal regeneration and plasticity after injury by interacting with the Nogo receptor (NgR1) complex. Nogo-A contains multiple inhibitory domains, including amino-Nogo and Nogo-66, which restrict axonal growth and contribute to the failure of CNS neurons to regenerate after injury. Besides its role in axonal inhibition, Reticulon-4/Nogo-A participates in the shaping of endoplasmic reticulum membranes and regulates protein folding by interacting with ER-resident proteins such as protein disulfide isomerase. Pathophysiologically, Nogo-A is implicated in neurodegenerative diseases, spinal cord injury, multiple sclerosis, and stroke, making it a significant target for therapeutics aimed at promoting neural regeneration and recovery in the CNS[1][2][3][4][5][6][7].
Inhibition of Nogo-A (for example, by anti-Nogo-A antibodies) neutralizes its axon growth-inhibiting effects, potentially promoting neural regeneration and functional recovery after CNS injury[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reticulon-4 (Nogo-A) (Nogo-A).